We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGTI
1676
DELISTED
PGT, Inc.
PGTI
$2.92M ﹤0.01%
152,648
-22,659
-13% -$484K
TUP
1677
DELISTED
Tupperware Brands Corporation
TUP
$2.92M ﹤0.01%
138,000
-17,870
-11% -$400K
PFSI icon
1678
PennyMac Financial
PFSI
$4.02B
$2.91M ﹤0.01%
47,664
-4,886
-9% -$310K
RILY icon
1679
BRC Group Holdings
RILY
$289M
$2.9M ﹤0.01%
49,102
-8,646
-15% -$567K
HLIO icon
1680
Helios Technologies
HLIO
$2.76B
$2.9M ﹤0.01%
35,252
+1,178
+3% +$96.1K
HLNE icon
1681
Hamilton Lane
HLNE
$5.57B
$2.89M ﹤0.01%
34,097
+1,449
+4% +$130K
LILAK icon
1682
Liberty Latin America Class C
LILAK
$1.64B
$2.89M ﹤0.01%
242,271
+6,032
+3% +$74.9K
HTO
1683
H2O America
HTO
$2.62B
$2.88M ﹤0.01%
43,560
+1,178
+3% +$79.5K
ITCI
1684
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.88M ﹤0.01%
77,196
+3,330
+5% +$116K
NARI
1685
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.87M ﹤0.01%
35,422
+1,317
+4% +$111K
WLK icon
1686
Westlake Corp
WLK
$9.9B
$2.87M ﹤0.01%
31,505
-1,123
-3% -$96.2K
CDLX icon
1687
Cardlytics
CDLX
$21.5M
$2.87M ﹤0.01%
3,416
+9
+0.3% +$9.13K
KAMN
1688
DELISTED
Kaman Corp
KAMN
$2.87M ﹤0.01%
80,342
-10,537
-12% -$435K
APAM icon
1689
Artisan Partners
APAM
$3.02B
$2.86M ﹤0.01%
58,417
-615
-1% -$31K
TILE icon
1690
Interface
TILE
$2.22B
$2.85M ﹤0.01%
188,225
-22,507
-11% -$324K
BHE icon
1691
Benchmark Electronics
BHE
$2.96B
$2.85M ﹤0.01%
106,687
-14,123
-12% -$375K
ANGO icon
1692
AngioDynamics
ANGO
$649M
$2.85M ﹤0.01%
109,798
-14,333
-12% -$383K
CYRX icon
1693
CryoPort
CYRX
$762M
$2.84M ﹤0.01%
42,682
+1,630
+4% +$101K
DCT
1694
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$2.84M ﹤0.01%
64,141
-4,120
-6% -$186K
VTLE
1695
DELISTED
Vital Energy
VTLE
$2.83M ﹤0.01%
34,958
+1,821
+5% +$111K
FIBK icon
1696
First Interstate BancSystem
FIBK
$3.58B
$2.83M ﹤0.01%
70,378
+14,238
+25% +$603K
GEO icon
1697
The GEO Group
GEO
$4.04B
$2.83M ﹤0.01%
378,682
-43,384
-10% -$319K
ARGO
1698
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$2.83M ﹤0.01%
54,127
+687
+1% +$36.1K
MNTV
1699
DELISTED
Momentive Global Inc. Common Stock
MNTV
$2.82M ﹤0.01%
143,650
+6,002
+4% +$122K
GTN icon
1700
Gray Television
GTN
$552M
$2.8M ﹤0.01%
122,896
+2,280
+2% +$50.5K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.